Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) study.
Journal article, 2010

Chronic heart failure with normal left ventricular ejection fraction (HFNEF) is not only common, but also carries a high risk of substantial morbidity and mortality. However, few studies have been conducted in this population and no proven treatment is available. Although beta-blockers are evidence-based first-line therapy in systolic heart failure, they have not been well studied in HFNEF.

Author

Jingmin Zhou

Haiming Shi

Yongxin Lu

Michael Fu

University of Gothenburg

Junbo Ge

European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology

1879-0844 (ISSN)

Vol. 12 2 181-5

Subject Categories

MEDICAL AND HEALTH SCIENCES

Cardiac and Cardiovascular Systems

DOI

10.1093/eurjhf/hfp193

PubMed

20083625

More information

Created

10/10/2017